NDC 62135-458 – Terazosin

Terazosin Hydrochloride 1 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC62135-458

Product details

Brand name
Terazosin
Generic name
Terazosin
Labeler
Chartwell RX, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075614
Marketed since
April 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (1)

Package NDCDescriptionSince
62135-458-9090 CAPSULE in 1 BOTTLE (62135-458-90)Feb 1, 2023

Other Terazosin products